Genecare Development Reduces Stake in TRANSTHERA-B, Sells 467,500 Shares at Approximately HK$12.58 Each

Stock News08-06

According to the latest data from the Hong Kong Stock Exchange, on August 5, Genecare Development Limited reduced its holdings in TRANSTHERA-B (02617) by 467,500 shares, with a transaction price of approximately HK$12.5786 per share, totaling about HK$5.8805 million.

Following the reduction, the latest number of shares held is approximately 21.4929 million, representing a stake of 6.87%.

This transaction involved other related parties, including Chan Tan Ching Fen, Ghalibo (PTC) Limited, Morningside Holdings (Asia) Limited, Morningside Bio-Ventures Limited, and Morningside Venture (I) Investments Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1123232974?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 19:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123232974","market":"fut","top_or_hot":-1,"title":"Genecare Development Reduces Stake in TRANSTHERA-B, Sells 467,500 Shares at Approximately HK$12.58 Each","media":"Stock News","content":"<p>According to the latest data from the Hong Kong Stock Exchange, on August 5, <b>Genecare Development Limited</b> reduced its holdings in <b>TRANSTHERA-B</b> (02617) by 467,500 shares, with a transaction price of approximately HK$12.5786 per share, totaling about HK$5.8805 million.<br><br>Following the reduction, the latest number of shares held is approximately 21.4929 million, representing a stake of 6.87%.<br><br>This transaction involved other related parties, including <b>Chan Tan Ching Fen</b>, <b>Ghalibo (PTC) Limited</b>, <b>Morningside Holdings (Asia) Limited</b>, <b>Morningside Bio-Ventures Limited</b>, and <b>Morningside Venture (I) Investments Limited</b>.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genecare Development Reduces Stake in TRANSTHERA-B, Sells 467,500 Shares at Approximately HK$12.58 Each</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenecare Development Reduces Stake in TRANSTHERA-B, Sells 467,500 Shares at Approximately HK$12.58 Each\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-06 19:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to the latest data from the Hong Kong Stock Exchange, on August 5, <b>Genecare Development Limited</b> reduced its holdings in <b>TRANSTHERA-B</b> (02617) by 467,500 shares, with a transaction price of approximately HK$12.5786 per share, totaling about HK$5.8805 million.<br><br>Following the reduction, the latest number of shares held is approximately 21.4929 million, representing a stake of 6.87%.<br><br>This transaction involved other related parties, including <b>Chan Tan Ching Fen</b>, <b>Ghalibo (PTC) Limited</b>, <b>Morningside Holdings (Asia) Limited</b>, <b>Morningside Bio-Ventures Limited</b>, and <b>Morningside Venture (I) Investments Limited</b>.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EWH","symbol_name":"香港ETF-iShares MSCI","start_time":0,"source_url":"","article_id":"1123232974","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123232974","pubTimestamp":1786015954,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"According to the latest data from the Hong Kong Stock Exchange, on August 5, Genecare Development Limited reduced its holdings in TRANSTHERA-B (02617) by 467,500 shares, with a transaction price of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EWH":"香港ETF-iShares MSCI","02617":"药捷安康-B","BK1161":"生物科技"},"translate_title":"Genecare Development减持TRANSTHERA-B股份，以每股约12.58港元出售467,500股股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EWH":1,"02617":1},"content_text":"According to the latest data from the Hong Kong Stock Exchange, on August 5, Genecare Development Limited reduced its holdings in TRANSTHERA-B (02617) by 467,500 shares, with a transaction price of approximately HK$12.5786 per share, totaling about HK$5.8805 million.Following the reduction, the latest number of shares held is approximately 21.4929 million, representing a stake of 6.87%.This transaction involved other related parties, including Chan Tan Ching Fen, Ghalibo (PTC) Limited, Morningside Holdings (Asia) Limited, Morningside Bio-Ventures Limited, and Morningside Venture (I) Investments Limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1123232974","isCrawlerRequest":true}